Rare diseases
Investigational molecules
Locations
147 conditions with trials, the busiest first
546 trials across Europe, recruiting first
Study on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients
BulgariaStudy on Aticaprant and Antidepressant for Preventing Relapse in Adults with Major Depressive Disorder and Anhedonia
BelgiumStudy on Lumateperone for Treating Manic Episodes in Bipolar I Disorder Patients
BulgariaStudy on Psilocybin, Ketamine, and Midazolam for Patients with Treatment-Resistant Depression
CzechiaStudy on the Effects and Safety of Piromelatine for Patients with Idiopathic Rapid Eye Movement Behavior Disorder (iRBD)
AustriaStudy on the Long-Term Safety of PTC923 (Sepiapterin) for Patients with Phenylketonuria
CzechiaStudy on Bepranemab for Patients with Early Alzheimer's Disease
BelgiumStudy on Long-Term Safety of Soticlestat for Patients with Dravet or Lennox-Gastaut Syndromes
BelgiumStudy on Long-Term Effects of Buprenorphine in Adults with Opioid Use Disorder
SwedenStudy on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer's Disease
FinlandStudy on the Effects of Gemlapodect for Adults and Adolescents with Tourette Syndrome
BelgiumStudy on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment
BulgariaThe therapies tested most often in Psychiatric disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
